We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Risk of Diabetes in Patients with Long-Standing Graves' Disease: A Longitudinal Study.
- Authors
Eyun Song; Min Ji Koo; Eunjin Noh; Soon Young Hwang; Min Jeong Park; Jung A. Kim; Eun Roh; Kyung Mook Choi; Sei Hyun Baik; Geum Joon Cho; Hye Jin Yoo
- Abstract
Background: The detrimental effects of excessive thyroid hormone on glucose metabolism have been widely investigated. However, the risk of diabetes in patients with long-standing hyperthyroidism, especially according to treatment modality, remains uncertain, with few longitudinal studies. Methods: The risk of diabetes in patients with Graves' disease treated with antithyroid drugs (ATDs) for longer than the conventional duration (≥2 years) was compared with that in age-and sex-matched controls. The risk was further compared according to subsequent treatment modalities after a 24-month course of ATD: continuation of ATD (ATD group) vs. radioactive iodine ablation (RIA) group. Results: A total of 4,593 patients were included. Diabetes was diagnosed in 751 (16.3%) patients over a follow-up of 7.3 years. The hazard ratio (HR) for diabetes, after adjusting for various known risk factors, was 1.18 (95% confidence interval [CI], 1.10 to 1.28) in patients with hyperthyroidism. Among the treatment modality groups, the RIA group (n=102) had a higher risk of diabetes than the ATD group (n=4,491) with HR of 1.56 (95% CI, 1.01 to 2.42). Further, the risk of diabetes increased with an increase in the ATD treatment duration (P for trend=0.019). Conclusion: The risk of diabetes was significantly higher in patients with long-standing Graves' disease than in the general population, especially in patients who underwent RIA and prolonged ATD treatment. Special attention to hyperglycemia during follow-up along with effective control of hyperthyroidism may be necessary to reduce the risk of diabetes in these patients.
- Subjects
PEOPLE with diabetes; IODINE isotopes; LONGITUDINAL method; THYROID antagonists; GLUCOSE metabolism
- Publication
Endocrinology & Metabolism, 2021, Vol 36, Issue 6, p1277
- ISSN
2093-596X
- Publication type
Article
- DOI
10.3803/EnM.2021.1251